Literature DB >> 20923881

Virus engineering: functionalization and stabilization.

Mauricio G Mateu1.   

Abstract

Chemically and/or genetically engineered viruses, viral capsids and viral-like particles carry the promise of important and diverse applications in biomedicine, biotechnology and nanotechnology. Potential uses include new vaccines, vectors for gene therapy and targeted drug delivery, contrast agents for molecular imaging and building blocks for the construction of nanostructured materials and electronic nanodevices. For many of the contemplated applications, the improvement of the physical stability of viral particles may be critical to adequately meet the demanding physicochemical conditions they may encounter during production, storage and/or medical or industrial use. The first part of this review attempts to provide an updated general overview of the fast-moving, interdisciplinary virus engineering field; the second part focuses specifically on the modification of the physical stability of viral particles by protein engineering, an emerging subject that has not been reviewed before.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923881     DOI: 10.1093/protein/gzq069

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  32 in total

1.  Detection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay.

Authors:  Jinsu Kim; Meena Adhikari; Sagar Dhamane; Anna E V Hagström; Katerina Kourentzi; Ulrich Strych; Richard C Willson; Jacinta C Conrad
Journal:  ACS Appl Mater Interfaces       Date:  2015-01-23       Impact factor: 9.229

Review 2.  Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

Authors:  Maria Yanqing Chen; Susan S Butler; Weitong Chen; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-11-08

Review 3.  Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature.

Authors:  Balabhaskar Prabhakarpandian; Ming-Che Shen; Kapil Pant; Mohammad F Kiani
Journal:  Microvasc Res       Date:  2011-07-02       Impact factor: 3.514

4.  Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo.

Authors:  Jan Ole Kemnade; Mamatha Seethammagari; Mathew Collinson-Pautz; Hardeep Kaur; David M Spencer; Alison A McCormick
Journal:  Vaccine       Date:  2014-06-09       Impact factor: 3.641

Review 5.  Virus capsid assembly across different length scales inspire the development of virus-based biomaterials.

Authors:  Ekaterina Selivanovitch; Trevor Douglas
Journal:  Curr Opin Virol       Date:  2019-05-06       Impact factor: 7.090

6.  Mechanical disassembly of single virus particles reveals kinetic intermediates predicted by theory.

Authors:  Milagros Castellanos; Rebeca Pérez; Pablo J P Carrillo; Pedro J de Pablo; Mauricio G Mateu
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

7.  Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions.

Authors:  Guangchuan Wang; Rui-Yuan Cao; Rong Chen; Lijuan Mo; Jian-Feng Han; Xiaoyu Wang; Xurong Xu; Tao Jiang; Yong-Qiang Deng; Ke Lyu; Shun-Ya Zhu; E-De Qin; Ruikang Tang; Cheng-Feng Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

8.  SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.

Authors:  Michelle L Ho; Benjamin A Adler; Michael L Torre; Jonathan J Silberg; Junghae Suh
Journal:  ACS Synth Biol       Date:  2013-08-22       Impact factor: 5.110

Review 9.  Synthetic immunosurveillance systems: nanodevices to monitor physiological events.

Authors:  Yvon L Woappi; Rahul Jangiti; Om V Singh
Journal:  Biosens Bioelectron       Date:  2014-05-10       Impact factor: 10.618

10.  Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.

Authors:  Giselle Rangel; Juan Bárcena; Noelia Moreno; Carlos P Mata; José R Castón; Alí Alejo; Esther Blanco
Journal:  Vaccines (Basel)       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.